Palatal involvement occurs commonly in patients with 22q11. 2 Deletion Syndrome (22qDS),
and includes palatal clefting and velopharyngeal dysfunction in the absence of overt or …

Objectives The aim of this study was to describe clinical features in subjects with palatal
abnormalities and to assess the distribution of these features among those with and without …

Abnormalities of the soft and hard palate are seen in approximately 70% of patients. Defects
range from overt clefts of the secondary palate to submucous clefts that may not be …

The purpose of the study was to investigate the prevalence of velopharyngeal impairment,
compensatory articulation, reduced intelligibility, and to rate the general impression of …

Background The 22q11. 2 chromosome deletion syndrome occurs at a frequency of 1 in
4000 live births. Fluorescent in situ hybridization is a reliable means of testing for this …

Objective To evaluate potential modifiers of the palatal phenotype in individuals with the
22q11. 2 deletion syndrome. Design Data from 356 subjects enrolled in a study of the …

Objective Velocardiofacial syndrome (VCFS) is the most common multiple anomaly disorder
associated with palatal clefting. Cytogenetic hemizygous deletion of 22q11 region is found …

Objective To describe the effect of time after velopharyngoplasty on outcome and to search
for preoperative prognostic factors for residual hypernasality in patients with 22q11. 2 …

Otorhinolaryngologic manifestations are common in 22q11. 2 deletion syndrome (22q11.
2DS), but poorly described. This study aimed to better define the ear‐nose‐throat (ENT) …

Objective To determine demographics and practice patterns of surgeons treating
velopharyngeal dysfunction (VPD) in patients with 22q11. 2 deletion syndrome (22q11 …